These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2389443

  • 1. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
    Buturović J, Kandus A, Malovrh M, Bren A, Drinovec J.
    Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
    [No Abstract] [Full Text] [Related]

  • 2. De novo occurrence of hemolytic-uremic syndrome in a cyclosporine-treated renal allograft patient.
    Verpooten GA, Paulus GJ, Roels F, De Broe ME.
    Transplant Proc; 1987 Apr; 19(2):2943-5. PubMed ID: 3551237
    [No Abstract] [Full Text] [Related]

  • 3. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.
    Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD.
    Surgery; 1985 Jul; 98(1):54-62. PubMed ID: 3892747
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients.
    Venkat KK, Tkach D, Kupin W, Mozes M, Oh HK, Raman BK, Visscher D, Lee MW.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1256-7. PubMed ID: 1989204
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Morphological analysis of glomerular lesions in renal transplants immunosuppressed with cyclosporine A (CYA): has CYA induced a new transplant glomerular lesion?
    Morozumi K, Yoshida A, Suganuma T, Satoh K, Aoki J, Oikawa T, Fujinami T, Uchida K, Yamada N, Orihara A.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):282-5. PubMed ID: 2650121
    [No Abstract] [Full Text] [Related]

  • 7. Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosis.
    Katznelson S, Wilkinson A, Rosenthal TR, Cohen A, Nast C, Danovitch GM.
    Transplant Proc; 1994 Oct; 26(5):2608-9. PubMed ID: 7940812
    [No Abstract] [Full Text] [Related]

  • 8. The impact of transplant aspiration cytology on management of cyclosporine A-treated renal transplant recipients.
    Yussim A, Shapira Z, Shmueli D, Heilbronn YD, Kaufman L, Servadio C.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1658-9. PubMed ID: 3274399
    [No Abstract] [Full Text] [Related]

  • 9. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
    Schmidt RJ, Venkat KK, Dumler F.
    Transplant Proc; 1991 Dec; 23(6):3156-7. PubMed ID: 1721390
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y, Nakhleh RE, Lee MW, Escobar FS, Venkat KK, Kupin WL, Mozes MF.
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [Abstract] [Full Text] [Related]

  • 11. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A, Pajek J, Grego K, Buturovic J, Ponikvar R, Lindic J, Knap B, Vizjak A, Ferluga D, Kandus A.
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.
    Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, DeMarco T.
    J Heart Lung Transplant; 1993 May; 12(3):440-4. PubMed ID: 8329415
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM, Murie JA, Allen R, Jaskowski A, Morris PJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Primary cadaveric renal transplantation using cyclosporine in patients over fifty years of age.
    Mandelbaum DM, Henry ML, Sommer BG, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1863-4. PubMed ID: 3274443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-reported change in physical symptoms from cyclosporine-based therapy to azathioprine-based therapy in heart transplant recipients.
    Lough ME, Miller JL, Gamberg P.
    J Heart Transplant; 1986 Feb; 5(4):322-6. PubMed ID: 3305825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.